Brief: Karolinska Development’s Portfolio Company Presents Positive Safety Data From First Part Of Phase 1b/2 Study In PBC

Kdventures AB

22/03/2024 09:21

March 22 (Reuters) - Karolinska Development AB
 KDEV.ST :
    * PORTFOLIO COMPANY UMECRINE COGNITION PRESENTS POSITIVE
SAFETY
DATA FROM THE FIRST PART OF ITS PHASE 1B/2 STUDY IN PBC

Source text for Eikon:  ID:nGNE5RhFLP 
Further company coverage:  KDEV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))